SAN FRANCISCO - Medical Devices Today has put together an exclusive roundup of the 18 early-stage high-growth technology companies that presented at the "Investment In Innovation (In3) Medical Device Summit" on June 17-19, 2008. (Part 3 of 3)
The In-3 Summit was presented by Medtech Insight/Windhover Information and FDC Reports.
The program featured 44 early- to late-stage medical technology company presentations focused into three concurrent market Tracks. For three consecutive issues, Medical Devices Today will feature a different track continuing this week with track two.
1) Cardio and Peripheral Vascular
2) Orthopedics and Spine, and
3) Other High-Growth Technologies
TRACK 3 - OTHER HIGH-GROWTH TECHNOLOGIES:
1) AltaScience Limited
Citywest Dublin, Ireland
AltaScience has developed a novel transcervical female sterilisation device which can be easily placed in the fallopian tubes though a hysteroscope.
With only one FDA approved device currently on the market in the US, this product is targeting a global market with potential sales of >$1 billion annually.
2) Ceragenix Pharmaceuticals
Las Vegas, NV
Ceragenix Pharmaceuticals is developing its "Cerashield" line of antimicrobial coatings to prevent microbial colonization and biofilm formation of endotracheal tubes and other indwelling medical devices.
3) CVAC Systems, Inc.
Temecula, CA
New platform device technology for the amelioration of diseases associated with insulin resistance. The flagship application will be diabetic neuropathy. 70% of type 2 diabetics have measurable neuropathy.
4) EyeGate Pharmaceuticals, Inc.
Waltham, MA
The EyeGateR II uses iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications.
5) Gel Delivery Solutions BV
The Netherlands
Gel Delivery Solutions develops an injectable synthetic polymer gel, that is 100% biodegradable in situ, sets at body temperature and provides slow release kinetics for proteins over days to months. Specifically targetted at closed tissue applications such as back-of eye, cranial and spinal delivery of advanced therapeutics.
6) GlucoLight Corporation
Bethlehem, PA
GlucoLight - GlucoLight is developing a continuous, non-invasive glucose monitor for the implementation of tight glycemic control in the hospitalized patient Healionics Corporation (First-Time Presenter) Redmond, WA Healionics develops biomaterials to enhance the biocompatibility and performance of current and next generation devices. Our core technology, STAR material, is a precisely engineered synthetic 3D tissue scaffold which promotes angiogenesis and tissue growth while reducing FBR.
7) InfraScan, Inc.
Philadelphia, PA
InfraScan, Inc. is a medical device start-up with the potential to become a leader in handheld diagnostic imaging devices. InfraScan is developing its flagship product, the Infrascanner™, which is a hand-held imaging device using near infrared (NIR) technologies for the detection of hematoma, or bleeding in the brain, in head trauma patients.
8) Keraderm LLC
Hampton, VA
Keraderm is an early stage medical device company commercializing a phototherapy treatment for nail fungal infections which is superior in efficacy and safety to current oral or topical treatments.
9) MicroPhage, Inc.
Longmont, CO
Bacteriophage enabling technology which offers the ability to increase specificity and decrease time to results on existing immunodiagnostic platforms.
10) MoleMap
Auckland, New Zealand
MoleMap is the world's most advanced melanoma screening programme designed to protect you and your family from the deadly effects of melanoma skin cancer by diagnosing it at the earliest possible stage.
11) Nanobiotix
LABEGE CEDEX, France
New treatments for cancer based on the combined application of nanotechnologies and biotechnologies.
12) Novian Health Inc.
Chicago, IL
Minimally-invasive procedure for ablation of breast tumors offering minimal scarring, quicker recovery times, and only requiring local anesthesia.
13) Photo Dynamic Therapy
Vienna, Austria
"Plug&play"-system to treat non-invasively curative and palliative tumors and precursors specific to patients' individual need.
14) Polymedix, Inc.
Radnor, PA
Novel anti-microbial polymeric coatings for devices and implants.
15) Softscope Medical Technologies
Plymouth, MN
Softscope Medical is developing an innovative endoscopic assist device designed to significantly improve flexible endoscopy procedures. The company's first product, a colonoscopy assist device, is designed to reduce procedure time and make the examination more comfortable for the patient.
Device also under development which will make complete small bowel endoscopy examinations practicable for the first time.
16) Vasorum Ltd
Citywest Dublin, Ireland
Vasorum Limited has developed the ideal arterial puncture closure device which provides immediate hemostasis in a fully anticoagulated environment, is simple to use, is deployed through the existing sheath and can be used to close high stick punctures. This device is the first true competitor to the leading product in this market with potential annual sales of >$1.5 billion.
17) Vironova AB
Nacka, Sweden
Vironova's operations are based on a unique proprietary image analysis technology which allows highly effective automated virus diagnostic and analysis for improved control and preparedness against emerging viruses linked to pandemics and/or bioterrorism.
18) Zassi Medical Evolutions Inc.
Fernandina Beach, FL
Zassi is developing a Continent Ostomy System that will restore continence control to individuals with abdominal ostomies and free them from 24/7 dependence on the "dreaded" ostomy pouch. The System is a unique combination of electrical stimulation technology with a multi-year stream of high margin, daily disposables.
